Hunan Nucien Pharmaceutical Co., Ltd. (SHSE: 688189)
Health Care · Pharmaceuticals · CN
CN¥6.50
-6.20% today · -56.0% 1Y
Hunan Nucien Pharmaceutical Co., Ltd. (SHSE: 688189) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $263.11M.
Over the last twelve months the share price has lost 56.0%, trading between 5.47 and 16.98.
Tweenvest scores Hunan Nucien Pharmaceutical Co., Ltd. across four factors: quality 57/100, value 42/100, growth 0/100. Its strongest factor is quality.
688189 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $263.11M
- Revenue (TTM)
- $18.46M
- P/E
- —
- EPS
- -0.52
- Dividend yield
- —
- Beta (5Y)
- 0.23
- 52-week high
- CN¥16.98
- 52-week low
- CN¥5.47
- Avg volume (3M)
- —
- Shares outstanding
- 272.11M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,189.41 | -3.59% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $270.00 | -1.15% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $153.10 | -2.14% |
| Roche Holding AGSWX: ROP | $371.62B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.30 | -0.95% |
Figures last refreshed Aug 18, 2026.